Polymyxin B is a powerful antibiotic medicine. It's made from bacteria and is used to treat serious infections caused by certain types of bacteria. It works by damaging the walls of the bacteria, helping them to die. However, it can sometimes cause side effects like nerve or kidney problems, so it's usually used carefully.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Polymyxin B is an older antibiotic that works against many gram-negative bacteria, a large group that includes Pseudomonas, Klebsiella, E. coli and Acinetobacter. Given by injection in the hospital, it treats serious infections of the bloodstream, urinary tract and, in special cases, the lining of the brain and spinal cord (meningitis). Because it can harm the kidneys and nerves, it is reserved for infections where safer antibiotics will not work or cannot be used. Today that mostly means infections caused by multidrug-resistant bacteria, such as strains resistant to carbapenems, which are usually among the most powerful antibiotics available. Newer antibiotics have become the preferred choice for many of these infections because they tend to work as well or better with less toxicity, so polymyxin B is often a last-line option, typically combined with a second antibiotic the bacteria are still sensitive to. The same ingredient also appears in very different, low-risk products: over-the-counter first aid ointments such as Polysporin and Neosporin for minor cuts, scrapes and burns, and prescription eye drops (combined with trimethoprim) for bacterial conjunctivitis and ear drops for outer ear infections. Little or no medicine reaches the bloodstream from these, so the serious risks described on this page apply to the injection.
Gram-negative bacteria are protected by an outer membrane, an extra wall that keeps many antibiotics out. Polymyxin B carries a positive electrical charge that lets it bind to negatively charged molecules in that membrane and break it open. The bacterial cell starts to leak and dies, which is why it kills bacteria rather than just stopping their growth. This mechanism explains its limits as well. It does nothing against gram-positive bacteria such as staph and strep, fungi or viruses. It is not absorbed when swallowed, so it has to be injected for infections inside the body. And human kidney and nerve cells can be damaged by the same membrane-disrupting action, which is the source of its main side effects.
For serious infections, polymyxin B is given into a vein (IV) as an infusion, usually every 12 hours, by hospital staff. Many specialists start with a larger first dose (a loading dose) to reach effective levels quickly. The dose is based on body weight. Injection into a muscle is rarely used because it is very painful. For meningitis, it may be given directly into the fluid around the spinal cord (intrathecally), because the IV form does not reach that fluid well. The length of treatment depends on the infection and how it responds. The care team checks blood tests, including kidney function, before and throughout treatment, and some hospitals measure drug levels in the blood to fine-tune the dose. First aid ointments are applied in a small amount to a cleaned minor wound one to three times a day; stop and ask a doctor if you need one for more than a week. Eye and ear drops are used on the schedule the prescriber gives.
Kidney injury is the most important side effect of injected polymyxin B and the main reason doses are limited. How often it happens varies widely between studies, partly because people receiving it are often very ill and on other kidney-stressing treatments. It usually shows up first on blood tests, which is why they are checked so often; passing much less urine is a sign to mention to the nurse right away. Polymyxin B can also affect nerves. Tingling or numbness around the mouth or in the hands and feet, dizziness, unsteadiness, unusual drowsiness or weakness, and blurred vision should be reported to the care team promptly. These effects are more likely when kidney function is reduced and drug levels build up. Other reactions include flushing of the face, fever, hives, pain or vein irritation where the IV runs, low potassium, calcium or magnesium on blood tests, and darkening of the skin on the face, neck and upper chest during treatment. Like other antibiotics, it can lead to an intestinal infection called C. diff. Watery or bloody diarrhea, with or without cramps or fever, should be reported promptly, including if it starts weeks after the last dose, since this can appear up to two months later. For the ointments, the main problem is an allergic skin rash; stop using it if a rash develops.
Rarely, injected polymyxin B can weaken the muscles used for breathing. This is most likely soon after general anesthesia or when it is combined with muscle relaxants given during surgery or intensive care, so the anesthesia team needs to know someone is receiving it. In hospital, breathing is watched and supported if needed. The care team tries to avoid giving it alongside other medicines that can harm the kidneys or nerves. These include aminoglycoside antibiotics such as gentamicin, tobramycin and amikacin, and colistin, a closely related polymyxin antibiotic. Sometimes this cannot be avoided in a severe infection, and closer monitoring is then needed. Polymyxin B should not be used by anyone who has had an allergic reaction to a polymyxin. Its safety in pregnancy has not been established, so it is used during pregnancy only when the infection's danger outweighs the uncertainty. Existing kidney disease does not rule it out, but it raises the stakes and makes monitoring more important.
Polymyxin B is almost always given to people who are already in the hospital, often in intensive care, after lab tests show or strongly suggest an infection with resistant bacteria. Choosing it usually involves an infectious disease specialist and depends on culture results that show which antibiotics the bacteria still respond to, so the treatment plan may change once those results arrive. During treatment, expect daily or near-daily blood tests, with attention to kidney function and salts like potassium and magnesium. If kidney numbers rise, the team weighs that against how dangerous the infection is; in a life-threatening infection they may continue at full dose, while in other cases they may stop or switch to a less toxic option. Response depends heavily on the type and site of infection and on overall health, and these infections can be hard to cure even with the best available treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Polymyxin B, what you've noticed, or ask the community a question.